EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Influenza and COVID-19 co-infection and vaccine effectiveness against severe cases: a mathematical modeling study

Jingyi Liang, Yangqianxi Wang, Zhijie Lin, Wei He, Jiaxi Sun, Qianyin Li, Mingyi Zhang, Zichen Chang, Yinqiu Guo, Wenting Zeng, Tie Liu, Zhiqi Zeng und 2 weitere

Frontiers in Cellular and Infection Microbiology · 04.03.2024 · 14

DOI: 10.3389/fcimb.2024.1347710 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 04.03.2024. Verfasst von Jingyi Liang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Engineering Science, Faculty of Innovation Engineering, Macau University of Science and Technology, Taipa, Macao SAR, China. Hauptthemen laut MEDLINE: Influenza Vaccines, Influenza, Human, COVID-19, Coinfection. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Influenza A virus have a distinctive ability to exacerbate SARS-CoV-2 infection proven by in vitro studies. Furthermore, clinical evidence suggests that co-infection with COVID-19 and influenza not only increases mortality but also prolongs the hospitalization of patients. COVID-19 is in a small-scale recurrent epidemic, increasing the likelihood of co-epidemic with seasonal influenza. The impact of co-infection with influenza virus and SARS-CoV-2 on the population remains unstudied.

Method

Here, we developed an age-specific compartmental model to simulate the co-circulation of COVID-19 and influenza and estimate the number of co-infected patients under different scenarios of prevalent virus type and vaccine coverage. To decrease the risk of the population developing severity, we investigated the minimum coverage required for the COVID-19 vaccine in conjunction with the influenza vaccine, particularly during co-epidemic seasons.

Result

Compared to the single epidemic, the transmission of the SARS-CoV-2 exhibits a lower trend and a delayed peak when co-epidemic with influenza. Number of co-infection cases is higher when SARS-CoV-2 co-epidemic with Influenza A virus than that with Influenza B virus. The number of co-infected cases increases as SARS-CoV-2 becomes more transmissible. As the proportion of individuals vaccinated with the COVID-19 vaccine and influenza vaccines increases, the peak number of co-infected severe illnesses and the number of severe illness cases decreases and the peak time is delayed, especially for those >60 years old.

Conclusion

To minimize the number of severe illnesses arising from co-infection of influenza and COVID-19, in conjunction vaccinations in the population are important, especially priority for the elderly.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza VaccinesInfluenza, HumanCOVID-19CoinfectionInfluenza A virusAgedHumansMiddle AgedCOVID-19 VaccinesVaccine EfficacySARS-CoV-2Vaccination

Stichwörter der Autor:innen

SARS-CoV-2co-infectioncompartmental modelinfluenzavaccination

Substanzen

Influenza VaccinesCOVID-19 Vaccines

Autor:innen und Institutionen

  • Department of Engineering Science, Faculty of Innovation Engineering, Macau University of Science and Technology, Taipa, Macao SAR, China.
  • Respiratory Disease AI Laboratory on Epidemic and Medical Big Data Instrument Applications, Faculty of Innovation Engineering, Macau University of Science and Technology, Macao, Macao SAR, China.
  • Guangzhou Key Laboratory for Clinical Rapid Diagnosis and Early Warning of Infectious Diseases, KingMed School of Laboratory Medicine, Guangzhou Medical University, Guangzhou, China.
  • State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou…
  • Guangzhou Laboratory, Guangzhou, Guangdong, China.

Zitieren

APA

Liang, J., Wang, Y., Lin, Z., He, W., Sun, J., Li, Q., Zhang, M., Chang, Z., Guo, Y., Zeng, W., Liu, T., Zeng, Z., Yang, Z., & Hon, C. (2024). Influenza and COVID-19 co-infection and vaccine effectiveness against severe cases: a mathematical modeling study. Frontiers in Cellular and Infection Microbiology, 14. https://doi.org/10.3389/fcimb.2024.1347710

Vancouver

Liang J, Wang Y, Lin Z, He W, Sun J, Li Q, et al. Influenza and COVID-19 co-infection and vaccine effectiveness against severe cases: a mathematical modeling study. Frontiers in Cellular and Infection Microbiology. 2024;14. doi:10.3389/fcimb.2024.1347710

BibTeX
@article{Liang2024,
  author = {Liang, Jingyi and Wang, Yangqianxi and Lin, Zhijie and He, Wei and Sun, Jiaxi and Li, Qianyin and Zhang, Mingyi and Chang, Zichen and Guo, Yinqiu and Zeng, Wenting and Liu, Tie and Zeng, Zhiqi and Yang, Zifeng and Hon, Chitin},
  title = {Influenza and COVID-19 co-infection and vaccine effectiveness against severe cases: a mathematical modeling study},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2024},
  volume = {14},
  doi = {10.3389/fcimb.2024.1347710}
}
Kostenlos starten →